Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
A Timeline of Rising Antisemitism in Australia - 2Computerized Strengthening d: A Survey of \Upgrading Efficiency\ Programming Application
- 3She was the supermodel dubbed 'The Face' in the '80s. Joining OnlyFans in her 60s taught her a lot.
- 44 injured in suburban Philadelphia nursing home explosion file negligence lawsuit
- 5Manual for Picking Coastline Travel
- Israeli lawmakers pass bill reviving death penalty for terrorists
- Reporter's Notebook: The Post embeds with foreign armies visiting the IDF
- Toddler given just 3 years to live after strange symptoms makes full recovery
- FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
- Record-breaking flu hospitalizations in New York in a single week: Health officials
- New funding transforms lives by expanding electricity access across Africa
- NASA's SPHEREx telescope completes its 1st cosmic map of the entire sky and it's stunning!
- First Houthi launch toward Israel since war began triggers alerts across the Negev
- Middle East hotels hit pandemic-era lows amid Iran war
